Institutes
September 21, 2021
Be a Part of the Cure Telethon Raises $400,000
The 2nd annual Be a Part of the Cure Telethon to benefit the UAMS Winthrop P. Rockefeller Cancer Institute’s research and treatment programs raised nearly $400,000 despite a second year of pandemic challenges. “Cancer has affected us all, and the Winthrop P. Rockefeller Cancer Institute continues to see patients, provide treatment and take care of…
September 20, 2021
Johnson Named UAMS Winthrop P. Rockefeller Cancer Institute Executive Director of Community Outreach and Engagement
Corey Johnson has joined the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as executive director of community outreach and engagement. Johnson will work closely with Pearl McElfish, Ph.D., community outreach and engagement associate director and vice chancellor for UAMS Northwest Regional Campus in Fayetteville, to lead community engagement…
September 13, 2021
UAMS Winthrop P. Rockefeller Cancer Institute Names Three to Board of Advisors
The board of advisors of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has announced the election of three new board members. The new members are Danyelle Musselman, Aimee Arzoumanian, MHA, and David Rainey, Ed.D. Musselman is co-chair of the American Cancer Society’s Coaches vs. Cancer Wives and…
September 9, 2021
UAMS Research Team Finds Potential Cause of COVID-19 ‘Long-haulers’
LITTLE ROCK — A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is an antibody that shows up weeks after an…
September 8, 2021
UAMS’ Institute for Digital Health & Innovation Receives $1.5 Million Grant to Enhance Traumatic Brain Injury Resources
LITTLE ROCK — The Institute for Digital Health & Innovation at the University of Arkansas for Medical Sciences (UAMS) received a grant to fund a $1.5 million project to enhance clinical and educational resources for Arkansans living with a traumatic brain injury (TBI). The Administration for Community Living, under the U.S. Department of Health and…
September 1, 2021
UAMS’ AR-Connect to Provide Mental Health Care to Those Displaced by Hurricane Ida
LITTLE ROCK — AR-Connect, a University of Arkansas for Medical Sciences (UAMS) program that provides mental health care via live video, is offering its services to Gulf Coast natives forced to relocate to Arkansas due to the devastation left behind by Hurricane Ida.
August 31, 2021
UAMS Wins AAMC Award for Outstanding Community Engagement
FAYETTEVILLE – The Association of American Medical Colleges (AAMC) recently bestowed its top honor for community engagement to the University of Arkansas for Medical Sciences (UAMS). The Spencer Foreman Award for Outstanding Community Engagement is presented annually to an AAMC-member medical school or teaching hospital with a long-standing, major institutional commitment to partnering with the…
Cornea Specialist Alireza Ghaffarieh, M.D., Joins UAMS Jones Eye Institute
LITTLE ROCK — Alireza Ghaffarieh, M.D., has joined the Harvey & Bernice Jones Eye Institute at the University of Arkansas for Medical Sciences (UAMS) as a cornea specialist. Ghaffarieh is currently accepting new patients and will serve as an assistant professor and director of ophthalmic pathology services in the UAMS College of Medicine Department of…
August 30, 2021
New UAMS Baptist Health Cancer Center Opens in North Little Rock
LITTLE ROCK — The first UAMS Baptist Health Cancer Center is now open on the campus of Baptist Health Medical Center in North Little Rock, bringing the full spectrum of cancer research, diagnostic and treatment services available at UAMS’ Winthrop P. Rockefeller Cancer Institute to more Arkansans.
August 25, 2021
NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study
Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).
Previous page Next page